Detection of resistance phenotypes in gram-negative bacteria;Detección fenotípica de mecanismos de resistencia en microorganismos gramnegativos

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 29, Issue 7, 2011, Pages 524-534

  Navarro, Ferran ^a,b   Calvo, Jorge ^c   Cantón, Rafael ^d   Fernández Cuenca, Felipe ^e   Mirelis, Beatriz ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Aminoglycosides; AmpC; Beta lactamases; Carbapenemases; Enterobacteriaceae; ESBL; Haemophilus; IRT; Neisseria; Non fermenters gram negative bacilli; Quinolones

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAMASE AMPC; CARBAPENEMASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; PLASMID DNA; QUINOLONE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; GENE MUTATION; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; IN VITRO STUDY; NEISSERIA; NONHUMAN; PHENOTYPE; REVIEW;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA; PHENOTYPE; PRACTICE GUIDELINES AS TOPIC;

EID: 79961021805     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2011.03.011     Document Type: Review

References (51)

1. Martínez-Martínez L, Calvo J. El problema creciente de la resistencia antibiótica en bacilos gramnegativos: situación actual. Enferm Infecc Microbiol Clin. 2010;28:25-31.
2. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Twentieth Informational Supplement. CLSI document M100-S20. Wayne, PA2010.
3. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Twentieth Informational Supplement. CLSI document. M100-S20-U (June 2010 Update). Wayne, PA2010.
4. Comité de l'Antibiogramme de la Société Française de Microbiologie. Recommandations 2010: Disponible en: http://www.sfm-microbiologie.org/UserFiles/file/casfm 2010.pdf.
5. European Committee on Antimicrobial Susceptibility Testing. EUCAST. 2011: Available in: http://www.eucast.org.
6. Cantón R, Alós JI, Baquero F, Calvo J, Campos J, Castillo J, et al. Recomendaciones para la selección de antimicrobianos en el estudio de la sensibilidad in vitro con sistemas automáticos y semiautomáticos. Enferm Infecc Microbiol Clin. 2007;25:394-400. (Pubitemid 47205136)
7. a Edición (11), 2000. Disponible en: http://www.seimc.org/documentos/protocolos/microbiologia/.
8. Briñas L, Zarazaga M, Saenz Y, Ruiz-Larrea F, Torres C. Beta-lactamases in ampicillin-resistant Escherichia coli isolates from foods, humans, and healthy animals. Antimicrob Agents Chemother. 2002;46:3156-63.
9. Cantón R, Morosini MI, de la Maza OM, de la Pedrosa EG. IRT and CMT beta-lactamases and inhibitor resistance. Clin Microbiol Infect. 2008;14 Suppl 1:S53-62.
10. Oteo J, Campos J, Lázaro E, Cuevas O, García-Cobos S, Pérez-Vázquez M, et al. Increased amoxicillin-clavulanic acid resistance in Escherichia coli blood isolates, Spain. Emerg Infect Dis. 2008;14:1259-62.
11. Miró E, Navarro F, Mirelis B, Sabaté M, Rivera A, Coll P, et al. Prevalence of clinical isolates of Escherichia coli producing inhibitor-resistant beta-lactamases at a university hospital in Barcelona, Spain, over a 3-year period. Antimicrob Agents Chemother. 2002;46:3991-4. (Pubitemid 35403281)
12. Martín O, Valverde A, Morosini MI, Rodríguez- Domínguez M, Rodríguez-Baños M, Coque TM, et al. Population analysis and epidemiological features of inhibitor-resistant-TEM-beta-lactamase- producing Escherichia coli isolates from both community and hospital settings in Madrid, Spain. J Clin Microbiol. 2010;48:2368-72.
13. Navarro F, Miró E, Mirelis B. Lectura interpretada del antibiograma de enterobacterias. Enferm Infecc Microbiol Clin. 2010;28:638-45.
14. Vila J, Marco F. Lectura interpretada del antibiograma de bacilos gramnegativos no fermentadores. Enferm Infecc Microbiol Clin. 2010;28:726-36.
15. a Edición (38), 2011. Disponible en: http://www.seimc.org/documentos/protocolos/microbiologia/.
16. Livermore DM. Defining an extended-spectrum beta-lactamase. Clin Microbiol Infect. 2008;14:3-10.
17. Bradford PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14:933-51.
18. Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother. 2010;54:969-76.
19. Diestra K, Coque TM, Miro E, Oteo J, Nicolau CJ, Campos J, et al. Caracterizacion y epidemiologia molecular de betalactamasas de espectro extendido en Escherichia coli y Klebsiella pneumoniae en once hospitales españoles (2004). Enferm Infecc Microbiol Clin. 2008;26:404-10.
20. Ángel-Díaz M, Ramón-Hernández J, Martínez-Martínez L, Rodriguez-Baño J, Pascual A. Escherichia coli y Klebsiella pneumoniae productoras de betalactamasas de espectro extendido en hospitales espanoles: segundo estudio multicentrico (proyecto GEIH-BLEE 2006). Enferm Infecc Microbiol Clin. 2009;27:503-10.
21. Truppia LA, Mollerach A, Di Conza JA, Radice M, Mugna V, Mendez E, et al. Comparación de tres métodos microbiológicos para la detección de betalactamasas de espectro extendido en enterobacterias aisladas en Santa Fe (Argentina). Enferm Infecc Microbiol Clin. 2005;23:525-8. (Pubitemid 41695909)
22. Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18:657-86.
23. Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev. 2009;22:161-82.
24. Mata C, Miró E, Rivera A, Mirelis B, Coll P, Navarro F. Prevalence of acquired AmpC beta-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007. Clin Microbiol Infect. 2010;16:472-6.
25. Mirelis B, Rivera A, Miró E, Mesa R, Navarro F, Coll P. A simple phenotypic method for differentiation between acquired and chromosomal AmpC beta-lactamases in Escherichia coli. Enferm Infecc Microbiol Clin. 2006;24:370-2. (Pubitemid 44133182)
26. Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, Gniadkowski M, et al. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect. 2010;16:112-22.
27. Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007;20:440-58.
28. Walsh TR. Emerging carbapenemases: a global perspective. Int J Antimicrob Agents. 2010;36:S8-14.
29. Oliver A. Impacto de la diseminación de Pseudomonas aeruginosa multirresistente productora de metalo-beta-lactamasas en los hospitales: presente y futuro. Enferm Infecc Microbiol Clin. 2009;27:255-6.
30. Juan Nicolau C, Oliver A. Carbapenemasas en Pseudomonas spp. Enferm Infecc Microbiol Clin. 2010;28:19-28.
31. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10:597-602.
32. Nordmann P, Poirel L, Carrër A, Toleman MA, Walsh TR. How to detect NDM-1 producers. J Clin Microbiol. 2011;49:718-21.
33. KPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain. J Antimicrob Chemother. 2010;65:1608-14.
34. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9:228-36.
35. Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH. Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect. 2001;7:88-91. (Pubitemid 34960278)
36. Carmeli Y, Akova M, Cornaglia G, Daikos GL, Garau J, Harbarth S, et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect. 2010;16:102-11.
37. Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother. 2010;65:1119-25.
38. Tato M, Coque TM, Ruíz-Garbajosa P, Pintado V, Cobo J, Sader HS, et al. Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity? Clin Infect Dis. 2007;45:1171-8.
39. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother. 2003;51:1109-17. (Pubitemid 36622067)
40. Jacoby GA. Mechanisms of resistance to quinolones. Clin Infect Dis. 2005;41:S120-126.
41. Martínez-Martínez L, Cano M, Rodríguez- Martínez J, Calvo J, Pascual A. Plasmid-mediated quinolone resistance. Expert Rev Anti Infect Ther. 2008;6:685-711.
42. Rodríguez-Martínez JM, Cano ME, Velasco C, Martínez-Martínez L, Pascual A. Plasmid-mediated quinolone resistance: an update. J Infect Chemother. 2011;17:149-82.
43. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev. 2009;22:664-89.
44. Schmitz FJ, Verhoef J, Fluit AC. Prevalence of aminoglycoside resistance in 20 European university hospitals participating in the European SENTRY Antimicrobial Surveillance Programme. Eur J Clin Microbiol Infect Dis. 1999;18:414-21. (Pubitemid 29531206)
45. Vakulenko SB, Mobashery S. Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev. 2003;16:430-50. (Pubitemid 36871315)
46. Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev. 2007;20:368-89. (Pubitemid 46709308)
47. Sanbongi Y, Suzuki T, Osaki Y, Senju N, Ida T, Ubukata K. Molecular evolution of beta-lactam-resistant Haemophilus influenzae: 9-year surveillance of penicillin-binding protein 3 mutations in isolates from Japan. Antimicrob Agents Chemother. 2006;50:2487-92. (Pubitemid 43993190)
48. García-Cobos S, Campos J, Román F, Carrera C, Pérez-Vázquez M, Aracil B, et al. Low beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains are best detected by testing amoxicillin susceptibility by the broth microdilution method. Antimicrob Agents Chemother. 2008;52:2407-14. (Pubitemid 351923072)
49. Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother. 2009;10:555-77.
50. Jorgensen JH, Crawford SA, Fulcher LC, Glennen A, Harrington SM, Swenson J, et al. Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis isolates. J Clin Microbiol. 2006;44:1744-54. (Pubitemid 43726264)
51. Vázquez JA, Enríquez R, Abad R, Alcalá B, Salcedo C, Arreaza L. Antibiotic resistant meningococci in Europe: any need to act? FEMS Microbiol Rev. 2007;31:64-70.